108 related articles for article (PubMed ID: 8604621)
21. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators.
Bittl JA; Strony J; Brinker JA; Ahmed WH; Meckel CR; Chaitman BR; Maraganore J; Deutsch E; Adelman B
N Engl J Med; 1995 Sep; 333(12):764-9. PubMed ID: 7643883
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin.
Ramana RK; Lewis BE
Vasc Health Risk Manag; 2008; 4(3):493-505. PubMed ID: 18827868
[TBL] [Abstract][Full Text] [Related]
23. Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.
Schulman SP; Goldschmidt-Clermont PJ; Topol EJ; Califf RM; Navetta FI; Willerson JT; Chandra NC; Guerci AD; Ferguson JJ; Harrington RA; Lincoff AM; Yakubov SJ; Bray PF; Bahr RD; Wolfe CL; Yock PG; Anderson HV; Nygaard TW; Mason SJ; Effron MB; Fatterpacker A; Raskin S; Smith J; Brashears L; Gottdiener P; du Mee C; Kitt MM; Gerstenblith G
Circulation; 1996 Nov; 94(9):2083-9. PubMed ID: 8901655
[TBL] [Abstract][Full Text] [Related]
24. Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in unstable angina pectoris.
Laskey MA; Deutsch E; Barnathan E; Laskey WK
Am J Cardiol; 1990 Jun; 65(22):1425-9. PubMed ID: 2353646
[TBL] [Abstract][Full Text] [Related]
25. Heparin infusion after successful percutaneous coronary intervention: a prospective, randomized trial.
Zibaeenezhad MJ; Mazloum Y
Acta Cardiol; 2009 Feb; 64(1):65-70. PubMed ID: 19317300
[TBL] [Abstract][Full Text] [Related]
26. Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
Roe MT; Granger CB; Puma JA; Hellkamp AS; Hochman JS; Ohman EM; White HD; Van de Werf F; Armstrong PW; Ellis SG; Califf RM; Topol EJ
Am J Cardiol; 2001 Dec; 88(12):1403-6, A6. PubMed ID: 11741559
[No Abstract] [Full Text] [Related]
27. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.
Kastrati A; Neumann FJ; Mehilli J; Byrne RA; Iijima R; Büttner HJ; Khattab AA; Schulz S; Blankenship JC; Pache J; Minners J; Seyfarth M; Graf I; Skelding KA; Dirschinger J; Richardt G; Berger PB; Schömig A;
N Engl J Med; 2008 Aug; 359(7):688-96. PubMed ID: 18703471
[TBL] [Abstract][Full Text] [Related]
28. The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.
Linder R; Oldgren J; Egberg N; Grip L; Larson G; Siegbahn A; Wallentin L
Eur Heart J; 1999 Apr; 20(7):506-18. PubMed ID: 10365287
[TBL] [Abstract][Full Text] [Related]
29. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
[TBL] [Abstract][Full Text] [Related]
30. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.
Mahaffey KW; Lewis BE; Wildermann NM; Berkowitz SD; Oliverio RM; Turco MA; Shalev Y; Ver Lee P; Traverse JH; Rodriguez AR; Ohman EM; Harrington RA; Califf RM;
J Invasive Cardiol; 2003 Nov; 15(11):611-6. PubMed ID: 14608128
[TBL] [Abstract][Full Text] [Related]
31. [Thrombosis and thrombocytopenia associated with the use of unfractionated heparin in a female patient with unstable angina].
Manito N; Alio J; Martínez Brotons F; Ballón H; Gausi C
Rev Clin Esp; 1991 Oct; 189(5):224-6. PubMed ID: 1666193
[TBL] [Abstract][Full Text] [Related]
32. Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty.
Doucet S; Malekianpour M; Théroux P; Bilodeau L; Côté G; de Guise P; Dupuis J; Joyal M; Gosselin G; Tanguay JF; Juneau M; Harel F; Nattel S; Tardif JC; Lespérance J
Circulation; 2000 Mar; 101(9):955-61. PubMed ID: 10704160
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.
van den Bos AA; Deckers JW; Heyndrickx GR; Laarman GJ; Suryapranata H; Zijlstra F; Close P; Rijnierse JJ; Buller HR; Serruys PW
Circulation; 1993 Nov; 88(5 Pt 1):2058-66. PubMed ID: 8222099
[TBL] [Abstract][Full Text] [Related]
34. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
35. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
36. Integration of anticoagulation, thrombolysis and coronary angioplasty for unstable angina pectoris.
Topol EJ
Am J Cardiol; 1991 Sep; 68(7):136B-141B. PubMed ID: 1892061
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial of a fixed high dose vs a weight-adjusted low dose of intravenous heparin during coronary angioplasty.
Boccara A; Benamer H; Juliard JM; Aubry P; Goy P; Himbert D; Karrillon GJ; Steg PG
Eur Heart J; 1997 Apr; 18(4):631-5. PubMed ID: 9129894
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of low-dose unfractionated heparin during percutaneous coronary revascularisation and the relationship between activated clotting time and haemorrhagic or ischaemic complications: our results.
Capuano C; Sesana M; Leonzi O; Cuccia C
J Cardiovasc Med (Hagerstown); 2006 Dec; 7(12):866-71. PubMed ID: 17122672
[TBL] [Abstract][Full Text] [Related]
39. Importance of delaying balloon angioplasty in patients with unstable angina pectoris.
Rozenman Y; Gilon D; Zelingher J; Sapoznikov D; Lotan C; Mosseri M; Weiss AT; Hasin Y; Gotsman MS
Clin Cardiol; 1996 Feb; 19(2):111-4. PubMed ID: 8821420
[TBL] [Abstract][Full Text] [Related]
40. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
